Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer

The mechanism of deleted in lymphocytic leukemia 2 (DLEU2)-long non-coding RNA in tumors has become a major point of interest in recent research related to the occurrence and development of a variety of tumors. Recent studies have shown that the long non-coding RNA DLEU2 (lncRNA-DLEU2) can cause abn...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Xue, Cao, Yu-xia, Xing, Yuan-xin, Liu, Qi, Li, Huan-jie, Yang, Wei-hua, Wang, Ban-qin, Han, Shu-yi, Wang, Yun-shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462543/
https://www.ncbi.nlm.nih.gov/pubmed/37095423
http://dx.doi.org/10.1007/s12094-023-03149-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462543/
https://www.ncbi.nlm.nih.gov/pubmed/37095423
http://dx.doi.org/10.1007/s12094-023-03149-x

Ejemplares similares